Anlotinib for Esophageal Cancer (AFEC)
NCT04966611 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2021-07-19
Summary
The purpose of this study is to observe and explore the effect of single or combined treatment of arotinib on the survival and prognosis of patients with advanced esophageal cancer in the real world, and to summarize the treatment experience of a wide range of people.
Conditions
- Esophageal Cancer
Interventions
- DRUG
-
This is an observational study
Sponsors & Collaborators
-
Anyang Tumor Hospital
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-07-15
- Primary Completion
- 2023-07-15
- Completion
- 2024-07-15
Countries
- China
Study Locations
More Related Trials
-
Apatinib as First -Line Treatment for Advanced Esophagus Cancer
NCT03542422 ·Status: UNKNOWN ·Phase: PHASE2
-
Apatinib Combined With Chemotherapy for Esophageal Squamous Cell Cancer After the Failure of Standard Treatment
NCT03224221 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Anlotinib in Patients With Esophageal Squamous Cell Carcinoma (ALTER1102)
NCT02649361 ·Status: COMPLETED ·Phase: PHASE2
-
Maintenance Chemotherapy With S-1, Locally Advanced Esophageal Cancer Receiving Definitive CCRT
NCT06598917 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
AN0025 and Chemoradiotherapy Combination in Esophageal Cancer
NCT05191667 ·Status: SUSPENDED ·Phase: PHASE1
-
Study of Anlotinib Plus Irinotecan in Patients With Esophageal Squamous Cell Carcinoma
NCT03387904 ·Status: UNKNOWN ·Phase: PHASE2
-
JMT101 Combined With Afatinib in Patients With Advanced Esophageal Squamous Cell Carcinoma After Standard Therapy
NCT05164848 ·Status: UNKNOWN ·Phase: PHASE1
-
Afatinib Plus Toripalimab in Previously Treated ESCC With EGFR Overexpression or EGFR Amplification
NCT04880811 ·Status: UNKNOWN ·Phase: PHASE2
-
AK104 Plus Concurrent Chemoradiation Therapy in Esophageal Squamous Cell Carcinoma
NCT05594914 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Apatinib for Esophageal Squamous Cell Cancer After the Failure of Standard Treatment
NCT02976896 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Neoadjuvant Therapy for the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma
NCT06354530 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Penpulimab Combined With Anlotinib and Chemotherapy
NCT06586242 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of Trifluridine/Tipiracil Combined With Anlotinib as Second-line Treatment for Recurrent and Metastatic Esophageal Squamous Cell Carcinoma
NCT07142421 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Neoadjuvant Chemoradiotherapy Combined With Perioperative Toripalimab in Locally Advanced Esophageal Cancer
NCT04437212 ·Status: UNKNOWN ·Phase: PHASE2
-
The Phase II Trial of SHR-1210 Combined With Preoperative Chemotherapy or Apatinib for Locally Advanced ESCC
NCT03917966 ·Status: UNKNOWN ·Phase: PHASE2
-
Neoadjuvant Therapy of Anlotinib Combined With Toripalimab and Chemotherapy for Resectable Esophageal Carcinoma
NCT05996484 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Study of Apatinib in Metastatic Esophageal Cancer
NCT02683655 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Atezolizumab Plus Tiragolumab in Combination With Paclitaxel and Cisplatin Compared With Paclitaxel and Cisplatin as First-Line Treatment in Participants With Unresectable Locally Advanced, Unresectable Recurrent, or Metastatic Esophageal Carcinoma
NCT04540211 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer
NCT04207918 ·Status: COMPLETED ·Phase: PHASE2
-
TC Plus PD-1 Inhibitors Combined With Anlotinib for Advanced Advanced Esophageal Cancer
NCT04471480 ·Status: UNKNOWN ·Phase: NA
-
Study of Nivolumab in Unresectable Advanced or Recurrent Esophageal Cancer
NCT02569242 ·Status: COMPLETED ·Phase: PHASE3
-
Apatinib Treatment for Advanced Esophagus Cancer
NCT03170310 ·Status: UNKNOWN ·Phase: PHASE2
-
High-dose Intensity Modulated Radiotherapy and Concurrent Chemotherapy in Esophageal Cancer
NCT03535207 ·Status: UNKNOWN ·Phase: NA
-
SOX-based CRT for Esophageal Cancer.
NCT03991104 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Definitive Proton Radiotherapy Combined With Chemotherapy and Immunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase I Clinical Study
NCT07034118 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1